Patents Assigned to Volopharm GmbH
  • Pharmaceutical preparation for treating benign prostatic hyperplasia
    Patent number: 8231870
    Abstract: The present invention relates to the use of at least one protease for the manufacture of a medicament for the treatment and/or prevention of benign prostate hypertrophy/hyperplasia, wherein the medicament is adapted for enteral administration, the at least one protease is selected from the group consisting of plant, non-mammalian animal and microbial proteases and the at least one protease is administered in an amount of 1 to 100 mg/kg body weight.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: July 31, 2012
    Assignee: Volopharm GmbH
    Inventors: Lucia Desser, Bernhard Lotz, Thomas Mohr
  • PHARMACEUTICAL PREPARATION FOR TREATING BENIGN PROSTATIC HYPERPLASIA
    Publication number: 20100254968
    Abstract: The present invention relates to the use of at least one protease for the manufacture of a medicament for the treatment and/or prevention of benign prostate hypertrophy/hyperplasia, wherein the medicament is adapted for enteral administration, the at least one protease is selected from the group consisting of plant, non-mammalian animal and microbial proteases and the at least one protease is administered in an amount of 1 to 100 mg/kg body weight.
    Type: Application
    Filed: December 3, 2008
    Publication date: October 7, 2010
    Applicant: Volopharm GmbH
    Inventors: Lucia Desser, Bernhard Lotz, Thomas Mohr